Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Digestive System Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03104582
What this trial is testing

Best Biliary Drainage Option in Advanced Klatskin Tumor

Who this might be right for
Cholangitis
Hepatopancreatobiliary Surgery Institute of Gansu Province 180
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07509424
What this trial is testing

Neoadjuvant Short-course Radiotherapy Followed by a Combination of Disitamab Vedotin, Sintilimab, and Capecitabine in Locally Advanced HER2-expressing Rectal Cance

Who this might be right for
Rectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 29
Testing effectiveness (Phase 2)Looking for participantsNCT07016724
What this trial is testing

Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 208
Testing effectiveness (Phase 2)UnknownNCT03280407
What this trial is testing

NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer

Who this might be right for
Colorectal NeoplasmColorectal CancerRectal Neoplasms+4 more
Zealand University Hospital 124
Testing effectiveness (Phase 2)Active Not RecruitingNCT06210971
What this trial is testing

Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer

Who this might be right for
Rectal Cancer
Hebei Medical University Fourth Hospital 60
Not applicableApproved For MarketingNCT02436044
What this trial is testing

HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC

Who this might be right for
Hepatocellular CarcinomaInjury; Blood Vessel, Hepatic, Artery
Ming Zhao
Testing effectiveness (Phase 2)Looking for participantsNCT07793695
What this trial is testing

Oral Zinc Supplementation Combined With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Anhui Provincial Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00956930
What this trial is testing

Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery

Who this might be right for
Liver Cancer
Northwestern University 45
Not applicableUnknownNCT01078311
What this trial is testing

Drug Monitoring of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Cancer
South West Sydney Local Health District 100
Not applicableUnknownNCT06258434
What this trial is testing

Liquid Biopsy Based Multiomics Study for Colorectal Cancer Early Screening

Who this might be right for
Colorectal CancerAdenomatous PolypsAdenoma+1 more
Sir Run Run Shaw Hospital 1,000
Testing effectiveness (Phase 2)Study completedNCT02620865
What this trial is testing

BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage III Pancreatic Cancer+1 more
Barbara Ann Karmanos Cancer Institute 2
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Large-scale testing (Phase 3)UnknownNCT00164892
What this trial is testing

Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial

Who this might be right for
Cancer of Stomach
Chinese University of Hong Kong 214
Early research (Phase 1)Study completedNCT00003799
What this trial is testing

Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer

Who this might be right for
Adenocarcinoma of the RectumMucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the Rectum+6 more
National Cancer Institute (NCI) 20
Large-scale testing (Phase 3)Study completedNCT00494299
What this trial is testing

Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE)

Who this might be right for
Carcinoma, Hepatocellular
Bayer 458
Testing effectiveness (Phase 2)UnknownNCT05896787
What this trial is testing

Candonilimab (AK104) Plus Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 45
Early research (Phase 1)WithdrawnNCT02288507
What this trial is testing

Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer

Who this might be right for
Hepatocellular Cancer
University of Hawaii
Testing effectiveness (Phase 2)UnknownNCT05225844
What this trial is testing

An Exploratory Trail of Camrelizumab Plus Apatinib Mesylate for Advanced Gastrointestinal

Who this might be right for
Gastrointestinal CancerImmunotherapyTargeted Therapy
Harbin Medical University 150
Early research (Phase 1)Study completedNCT04242199
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+9 more
Incyte Corporation 182
Testing effectiveness (Phase 2)Study completedNCT03861793
What this trial is testing

A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2)

Who this might be right for
Advanced Solid Tumors
Mural Oncology, Inc 116
Next Page